rs764645698
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_018834.6(MATR3):c.2161G>A(p.Glu721Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000242 in 1,614,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018834.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MATR3 | NM_018834.6 | c.2161G>A | p.Glu721Lys | missense_variant | Exon 13 of 15 | ENST00000394805.8 | NP_061322.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MATR3 | ENST00000394805.8 | c.2161G>A | p.Glu721Lys | missense_variant | Exon 13 of 15 | 1 | NM_018834.6 | ENSP00000378284.3 | ||
MATR3 | ENST00000394800.6 | c.2305G>A | p.Glu769Lys | missense_variant | Exon 17 of 19 | 5 | ENSP00000378279.2 | |||
MATR3 | ENST00000502929.5 | c.2305G>A | p.Glu769Lys | missense_variant | Exon 18 of 20 | 2 | ENSP00000422319.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251426Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135902
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000303 AC XY: 22AN XY: 727248
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 21 Uncertain:2
- -
This sequence change replaces glutamic acid with lysine at codon 721 of the MATR3 protein (p.Glu721Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs764645698, ExAC 0.003%). This variant has not been reported in the literature in individuals affected with MATR3-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at